[Changes in the direction of the immunomodulating activity of a purified staphylococcal anatoxin when administered to virus-infected mice].
Kalenderov
A K
AK
Semenova
I B
IB
Akatov
A K
AK
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D004353:Drug Evaluation, Preclinical; D002141:Encephalitis Virus, California; D004670:Encephalitis, California / Q000276:immunology / Q000628:therapy*; D007108:Immune Tolerance / Q000187:drug effects; D051379:Mice; D008808:Mice, Inbred CBA; D013208:Staphylococcal Toxoid / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
D000276:Adjuvants, Immunologic; D013208:Staphylococcal Toxoid
Izmenenie napravlennosti immunomoduliruiushcheĭ aktivnosti anatoksina stafilokokkovogo ochishchennogo (ASO) pri vvedenii zarazhennym virusom mysham.